The p300 Inhibitor A-485 Exerts Antitumor Activity in Growth Hormone Pituitary Adenoma.
Chenxing JiWen XuHong DingZhengyuan ChenChengzhang ShiJie HanLiang YuNidan QiaoYichao ZhangXiaoyun CaoXiang ZhouHaixia ChengHuijin FengCheng LuoZhiyu LiBing ZhouZhao YeYao ZhaoPublished in: The Journal of clinical endocrinology and metabolism (2022)
Our findings demonstrate that inhibition of HAT p300 by its selective inhibitor A-485 is a promising therapy for GHPA.
Keyphrases